Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat-labile enterotoxin subunit B (LT-B) is a non-toxic component of the heat-labile enterotoxin (LT) produced by enterotoxigenic Escherichia coli (ETEC). It is responsible for binding to ganglioside GM1 receptors on host cell membranes, facilitating entry of the toxic A subunit into target cells. LT-B is highly immunogenic and used in vaccine development as an antigen and mucosal adjuvant.
Binds to ganglioside GM1 receptors on intestinal epithelial cells, facilitating entry of the heat-labile enterotoxin A subunit.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat-labile enterotoxin subunit B (LT-B).